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Ceramide synthesis in the endoplasmic reticulum can
permeabilize mitochondria to proapoptotic proteins
Johnny Stiban, Laura Caputo, and Marco Colombini1
Department of Biology, University of Maryland, College Park, MD 20742
Abstract Increased mitochondrial ceramide levels are as-
sociated with the initiation of apoptosis. There is evidence
that ceramide is causal. Thus, the conversion of the pre-
cursor, dihydroceramide, to ceramide by the enzyme dihy-
droceramide desaturase may be important in preparing the
cell for apoptosis. Ceramide can initiate apoptosis by perme-
abilizing the mitochondrial outer membrane to apoptosis-
inducing proteins. However, the mitochondrion’s ability
to produce ceramide may be limited by its proteome. Here,
we show that ceramide synthesized in isolated mamma-
lian endoplasmic reticulum (ER) vesicles from either C8-
dihydroceramide or sphingosine to produce long-chain
ceramide can transfer to isolated mitochondria. The rate
of transfer is consistent with a simple collision model. The
transfer of the long-chain ceramide is faster than expected
for an uncatalyzed process. Sufficient ceramide is transferred
to permeabilize the outer membrane to cytochrome c and
adenylate kinase. The mitochondria-associated membranes,
ER-like membranes that are tightly associated with isolated
mitochondria, can produce enough ceramide to permeabilize
the outer membrane transiently. Thus, this ceramide ex-
change obviates the need for a complete ceramide de novo
pathway in mitochondria to increase ceramide levels to the
critical value required for functional changes, such as cer-
amide channel self-assembly followed by protein release.—
Stiban, J., L. Caputo, and M. Colombini. Ceramide synthesis
in the endoplasmic reticulum can permeabilize mitochondria
to proapoptotic proteins. J. Lipid Res. 2008. 49: 625–634.
Supplementary key words lipid transport & mitochondria-associated
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Apoptosis is a form of programmed cell death by which
cells perish without harming surrounding cells. Mitochon-
dria can initiate apoptosis by releasing key proteins (1, 2).
Many factors are known to contribute to the initiation of
mitochondria-mediated apoptosis, but the factors respon-
sible for the crucial, decision-making step, the formation
of the protein release pathway in the outer membrane, are
still debated. In addition to generally accepted factors
such as Bid, Bax, and Bak, the sphingolipid ceramide was
shown to be able to form large, stable, protein-permeable
channels in planar phospholipid membranes (3), in iso-
lated mitochondria (4), and in liposomes (5). Ceramide
channel formation depends, in part, on the steady-state
level of free ceramide in the membrane; thus, increased
ceramide levels in mitochondria lead to channel forma-
tion and protein release (6).
Ceramide generation varies depending on location,
forming different pools of ceramide that serve diverse
functions (7, 8). The highly insoluble nature of ceramide
means that there is a large energy barrier inhibiting the
movement of ceramide from one membrane to another,
thus tending to isolate the different pools. The two major
pathways of ceramide generation are sphingomyelin hy-
drolysis and de novo synthesis. The former occurs in a
variety of membranous systems, including the plasma
membrane (9), whereas the latter is mainly found in
the outer leaflet of the endoplasmic reticulum (ER)
(10). The de novo synthesis (for reviews, see Refs. 11,
12) involves the condensation of serine with a fatty acyl-
CoA (normally, palmitoyl-CoA). This reaction, catalyzed
by serine palmitoyltransferase complex (13, 14), pro-
duces ketosphinganine, which, after being reduced to
sphinganine (dihydrosphingosine), is N-acylated to dihy-
droceramide by ceramide synthase. The oxidation of di-
hydroceramide at the 4,5 position by dihydroceramide
desaturase (DDase) produces ceramide.
Many reports (reviewed in Ref. 11) suggest the impor-
tance of the de novo pathway in producing the ceramide
that is involved in mitochondria-mediated apoptosis. The
source of this ceramide is unclear. Ceramide synthase
has been found in mitochondria (15). In addition, cer-
amidase has also been demonstrated there, and this
enzyme can drive the synthesis of ceramide through a
reverse ceramidase activity (15–17). Moreover, mitochon-
dria are closely associated with smooth membranous sacs
that resemble the ER membranes. These ER-like mem-
branes are referred to as mitochondria-associated mem-
branes (MAMs) (18–22). Thus, perhaps ceramide is made
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in these membranes and transferred to mitochondria. A
soluble protein called CERT has been described that car-
ries ceramide from the ER to the Golgi apparatus (23).
Perhaps some unknown protein might deliver ceramide
to mitochondria. Finally, the demonstration that sphingo-
myelinase targeted specifically to mitochondria induces
apoptosis (24) indicates that the sphingomyelinase pathway
is not important in mitochondria, because normally there is
insufficient sphingomyelinase activity to induce apoptosis.
In this study, we provide evidence that ceramide made
in ER membranes can move to mitochondria and that
sufficient amounts are translocated to result in the per-
meabilization of the outer membrane to proteins.
MATERIALS AND METHODS
Rats (Sprague-Dawley males) were euthanized in conformity
with Public Health Service policy, and the protocol was approved
by the University of Maryland Institutional Animal Care and
Use Committee.
Materials
C2-dihydroceramide, C8-ceramide, C8-dihydroceramide C16-
ceramide, C16-dihydroceramide, and sphinganine were purchased
from Avanti Polar Lipids (Alabaster, AL). Horse heart cytochrome
c, BSA (fatty acid-depleted), and cholesterol were from Sigma
(St. Louis, MO). Sodium ascorbate, sodium borate, and 99.9% dry
ethylacetate were bought from Acros Organics (Geel, Belgium).
[14C]octanoic acid and [3H]sphingosine were from American
Radiolabeled Chemicals (St. Louis, MO). N-Hydroxysuccinimide
and dicyclohexylcarbodiimide were from Fisher Scientific. Thin-
layer chromatography was performed on Analtech (Newark, DE)
silica gel plates. Analytical-grade DMSO (Fisher Scientific) was
used to dissolve C2-dihydroceramide, whereas isopropanol (Acros
Organics) was used to dissolve C8-ceramide, C8-dihydroceramide,
C16-ceramide, and C16-dihydroceramide.
Preparation of radiolabeled C8-dihydroceramide
Sphinganine was acetylated using [1-14C]octanoic acid, ac-
cording to the procedure of Schulze, Michel, and van Echten-
Deckert (25). Four sealed, septum-topped, argon-flushed reaction
vials were used to minimize any contact with water vapor or air.
In the first vial, 5 ml containing 5 mCi of radioactive octanoic
acid (specific activity, 55 mCi/mmol) was mixed with 13 ml of
10 mg/ml cold octanoic acid (in ethylacetate). In total, 1 mmol
of octanoic acid was used. The solvent was flushed with a stream
of argon, and then 1 ml of 99.9% ethylacetate was added to
the vial. After mixing for 5 min, the solution was transferred to
the second reaction vial, which already contained 4 ml of 0.25 M
N-hydroxysuccinimide (1 mmol) and had been flushed with
argon. After mixing for 5 min, the solution was injected in the
third vial. The latter had 1 mmol of dicyclohexylcarbodiimide
(1 ml of 1 M). This reaction was carried overnight. The next day,
the solution was transferred into the fourth vial, which contained
0.87 mg (2.6 mmol) of sphinganine. The acylation reaction was
carried over 3 days, and at the end of the third day, the reaction
mixture was dried under nitrogen and the products were dis-
solved in 30 ml of CHCl3/CH3OH (1:1, v/v) and applied to a TLC
plate. The vial was rinsed with 30 ml of CHCl3/CH3OH (1:1, v/v)
three times and also applied to the TLC plate (to recover essen-
tially all of the radioactivity). The developing system was CHCl3/
CH3OH/H2O (80:10:1, v/v/v). By TLC, the radioactive band
was recovered after being detected with a Geiger-Mu¨ller counter,
scrapped off the silica gel, and extracted in CHCl3/CH3OH
(2:1, v/v). Multiple extractions of the silica gel were made.
Further separation of octanoic acid from the product N-[1-
14C]octanoyl-D-erythro-sphinganine (1-14C-DHC8), or C8-dihydro-
ceramide, was not needed because the reaction apparently
consumed all reactants (as shown by the visualization of the plate
in a PhosphorImager). The final concentration of 1-14C-DHC8
was 18 mM in isopropanol.
Mitochondria
Mitochondria were isolated from male Sprague-Dawley rat
liver as described by Parsons, Williams, and Chance (26) as mod-
ified (4, 5). Briefly, livers from overnight-fasted young rats (gen-
erally, 200–300 g) were obtained and cut in ice-cold isolation
buffer (210 mM mannitol, 70 mM sucrose, 10 mM HEPES,
0.1 mM EGTA, and 0.05 mg/ml fatty acid-free BSA, pH 7.4;
HB buffer). The liver was minced and homogenized in a mo-
torized Potter homogenizer with a loose Teflon pestle (two
passes). Differential centrifugation followed, starting at 760 g for
10 min at 4jC. To recover the mitochondria, the supernatant was
then spun for 10 min at 9,000 g. The supernatant of this spin was
used to isolate ER (see below). This sequence was repeated, but
the second high-speed spin was performed with HB buffer
lacking BSA (i.e., H buffer). Finally, the mitochondrial pellet was
gently resuspended in H buffer.
The protein concentration of the mitochondrial suspension
was measured using a spectroscopic method (27). Reduced cyto-
chrome c was prepared by mixing 5.5 mg of cytochrome c with
2 mg of sodium ascorbate in 0.25 ml of buffer Q (200 mM HEPES
and 10 mM EGTA, pH 7.5). The reduced cytochrome c was se-
parated from the ascorbate on a Sephadex G-10 gel filtration
column preequilibrated with buffer Q (after elution, the con-
centration of reduced cytochrome c is ?1 mM).
Ultrapure mitochondria isolation
Mitochondria isolated by differential centrifugation were
layered on top on a 28% self-generating Percoll gradient accord-
ing to Holden and Colombini (28), and the tube was spun at
39,000 gmax for 30 min. The mitochondrial fraction was collected
and diluted in H buffer and spun at 9,000 g for 10 min to remove
the Percoll.
The ER
Here, we use the term ER for the isolated microsomes, which
have different components but are mostly composed of ER
membranes. The ER was separated according to a slight modi-
fication of a published procedure (25). Briefly, the first 9,000 g
supernatant from the mitochondrial isolation was spun down
at 105,000 g for 1 h. The pellet was suspended in H buffer and
centrifuged again at 9,000 g for 10 min. The supernatant rep-
resents the ER fraction. The protein concentration in the super-
natant was determined using the bicinchoninic acid protein assay
kit from Pierce (Rockford, IL).
Desaturase assay
Desaturase activity was assayed in mitochondrial and ER frac-
tions according to a published procedure (25). One modification
was the use of isopropanol to dissolve dihydroceramides before
dispersal into the aqueous phases. We chose conditions and
concentrations of these agents that resulted in no significant
sedimentation of dihydroceramide micelles (.99% of the radio-
activity remained in the supernatant when the solution was
centrifuged at 105,000 g, the speed used to sediment ER). By
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contrast, dispersal of ceramide dissolved in either ethanol or
DMSO results in its sedimentation unless special precautions
are taken (6).
Mitochondrial inner membrane desaturase assay
Three hundred microliters of 21 mg/ml mitochondria was
mildly shocked by adding 0.9 ml of double distilled water and
kept on ice for 5 min. Osmolarity was restored by adding 0.9 ml
of R32 buffer (0.6 M mannitol, 20 mM NaH2PO4, 10 mM
MgCl2, and 20 mM KCl, pH 7.2). The final concentration of
mitochondria was 3 mg/ml. To assess DDase activity, to 1 ml of
the shocked mitochondria was added 36 ml of M/G buffer
(70 mM malate and 70 mM glutamate, K1 salt, pH 7.3) to gen-
erate NADH in the matrix, 40 ml of 0.1 M NADH (to supply the
NADH to the medium), and 10 ml of 1-14C-DHC8. The reaction
was run for 45 min at 37jC before being stopped by the addition
of 1.5 ml of CHCl3/CH3OH (2:1, v/v). In the control experi-
ment, the reaction was stopped immediately after the addition
of the radiolabeled compound. The lipids were isolated as de-
scribed below.
Separation of C8 from DHC8
The protocol of Schulze, Michel, and van Echten-Deckert (25)
was followed. Basically, a TLC plate impregnated with borax
was used to separate ceramide from dihydroceramide. A 70 mM
suspension of sodium borate in methanol was poured on a silica
gel TLC plate and incubated for 30 min. The plates were re-
moved and dried at room temperature for 2 h. After the lipids
were extracted, they were spotted on the borax-impregnated
plates. The developing system for the separation was 9:1 (v/v)
CHCl3/CH3OH.
Visualization of the radiolabeled bands
After the TLC plates were developed, they were air-dried
and then stored in contact with a PhosphorImager screen
(Amersham Biosciences) in a dark cassette for a minimum of
3 days. The screen was then scanned in a Storm PhosphorImager.
Medium-chain lipid transfer experiments
The transfer of radiolabeled lipids from the ER to mitochon-
dria was measured as follows. A total of 750 ml of 3 mg/ml ER
was incubated with 10 ml of 1-14C-DHC8 and 40 ml of 0.1 M
NADH for 45 min. An equivalent amount of mitochondria was
added, resulting in a total volume of 1.5 ml. The tube was
vortexed and incubated at 37jC for 2, 5, or 10 min before being
spun down at 9,000 g for 10 min. Aliquots were taken from the
pellet (mitochondria) and supernatant (ER) to measure total
radioactivity, then CHCl3/CH3OH (2:1, v/v) was added to each
fraction to isolate the lipids. The lipids were extracted and run
on a TLC plate. The radioactive bands were visualized as in-
dicated above.
Long-chain lipid transfer experiments
ER preparations (8.1 ml of 3 mg/ml protein) were mixed with
1.5 ml of [3H]sphingosine (1.5 mCi; specific activity, 20 Ci/mmol)
with and without 100 mM palmitoyl-CoA (900 ml of 1 mM) and
incubated at 37jC for 15 min (29). After incubation, excess
sphingosine was removed by the addition of 63 mg of fatty acid-
free BSA and spinning down the ER at 105,000 g for 1 h. This step
was repeated twice. After resuspending the ER pellet in 9 ml of H
medium and distributing it in three tubes, mitochondria (3 ml of
3 mg/ml protein) were gently mixed with the ER preparations
carrying the radiolabeled ceramide and the tubes were incubated
for 0, 5, and 10 min at room temperature before spinning at low
speed (9,000 g for 10 min) to recover mitochondria and then at
high speed (105,000 g for 1 h) to retrieve the ER. For the control
(no palmitoyl-CoA), the incubation with mitochondria was per-
formed for 10 min only. Aliquots from the pellets were taken to
measure the ER marker enzyme. The lipids were extracted from
the pellets with CHCl3/CH3OH (2:1, v/v), and samples were
counted in a scintillation counter. The rest of the extracted lipids
were dried down under nitrogen and house vacuum overnight
and applied to a TLC plate. The mobile phase used was 99:1 (v/v)
diethylether/CH3OH (29). The ceramide and sphingosine bands
were scraped off and counted.
Permeabilization of the mitochondrial outer membrane
after NADH and dihydroceramide addition
Mitochondria (50 ml of 3 mg protein/ml) were suspended in
0.75 ml of isotonic H buffer and incubated with 20 ml of 4 mM
NADH (0.1 mM) and 10 ml of 1 mg/ml N-palmitoyl-D-erythro-
sphinganine (DHC16; 19 nmol) for various times. After the in-
cubation, the mitochondria were spun down at 6,500 rpm
for 5 min (at 4jC) before being gently resuspended in 0.75 ml
of H buffer supplemented with 2.2 mM antimycin A and 2 mM
2,4-dinitrophenol (HAD buffer). At time zero, 15 ml of 1 mM
reduced cytochrome c was added. The initial rate of the reduc-
tion of absorbance at 550 nm of the added cytochrome c was
used as a measure of the permeabilization of the mitochondrial
outer membrane (4, 5). It was expressed as a percentage of
the rate measured with the same amount on hypotonically
shocked mitochondria. Vehicle control treatments were per-
formed as appropriate.
Monitoring outer membrane permeability after exposure
to ER
Isolated ER (2 mg of protein) was preincubated with 3 mM
NADH and 28 nmol DHC16 in 1 ml of H buffer for 0, 20, 45, and
80 min. The control lacked NADH and DHC16. At each time
point, 50 ml of the ER (control or experimental) was mixed with
50 ml of 0.5 mg protein/ml mitochondria in 0.75 ml of HAD
buffer and incubated for 10 min before 15 ml of 1 mM reduced
cytochrome c was added to measure the cytochrome c oxidation
rate. The difference in absorbance at 550 and 600 nm was used
to record the cytochrome c oxidation, because adding ER to
mitochondria caused an increase in light scattering with time
(increasing the baseline at 600 nm). Also, incubating the ER by
itself (no mitochondria) had a baseline of cytochrome c oxida-
tion, indicating some contamination with mitochondria. The
baseline rate of cytochrome c oxidation by ER vesicles was sub-
tracted from the rate measured in each experimental treatment
with ER.
Release of adenylate kinase
Isolated mitochondria (200 mg of protein) were incubated in
3 ml of H buffer and 1 ml of 5 mg/ml leupeptin, 1 ml of 5 mg/ml
aprotinin, and 1 ml of 5 mg/ml pepstatin. This was the control,
untreated sample. At time points 0, 5, and 15 min, 1 ml was taken
out and spun at 14,000 rpm. A total of 900 ml of supernatant was
recovered and put on ice. In each experiment, 300 ml of the
supernatant was mixed with 700 ml of the reaction mixture
containing 50 mM Tris (pH 7.5), 5 mM MgSO4, 10 mM glucose,
1 mM ADP, and 0.2 mM NADP1. After waiting for 1 min, 9 ml
of the enzyme mixture (25 units of hexokinase and 25 units of
glucose-6-phosphate dehydrogenase) was added, and the pro-
duction of NADPH at 340 nm was monitored. In the experimen-
tal trials, 2.4 mM NADH, 74 nmol of DHC16, or 2.4 mM NADH1
74 nmol DHC16 was added to the control mixture. The spectro-
photometer was blanked with the appropriate solution.
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ER marker enzyme assay
The marker enzyme for the ER was NADPH:cytochrome c reduc-
tase,andtheassaywasaccordingtoErnster,Siekevitz,andPalade(30).
RESULTS
Incubating mitochondria with NADH and long-chain
dihydroceramide permeabilizes the outer membrane
to adenylate kinase and cytochrome c
It has been shown that the addition of ceramide to iso-
lated mitochondria leads to the permeabilization of the
outer membrane to proteins (4–6). Mitochondria isolated
by differential centrifugation were incubated with NADH
and long-chain DHC16. At the indicated times (Fig. 1A),
they were centrifuged to remove the excess NADH and
tested for their ability to oxidize exogenously added cyto-
chrome c. The rate of cytochrome c oxidation is a measure
of the permeabilization of the outer membrane to pro-
teins and is expressed as a percentage of the rate measured
after damaging the outer membrane by hypotonic shock.
The permeabilization was plotted as a function of time
of incubation with NADH and DHC16 (Fig. 1A). The per-
meabilization of the outer membrane to cytochrome c that
Fig. 1. Permeabilization of mitochondrial outer membranes to cytochrome c and adenylate kinase by incubating mitochondria with
NADH and dihydroceramide. A: Mitochondria were exposed to NADH and N-palmitoyl-D-erythro-sphinganine (DHC16)-ceramide at 20jC
(closed circles) and 37jC (open circles) for the indicated times, and then their ability to oxidize cytochrome c was measured to estimate the
degree of permeabilization of the outer membrane to proteins. The cytochrome c oxidation rate is expressed as a percentage of the rate
observed with hypotonically shocked mitochondria. B: The experiment in A was performed under a variety of conditions. Fifty microliters of
3 mg/ml rat liver mitochondria obtained by differential centrifugation was incubated with the indicated compounds for 30 min followed by
centrifugation to remove the supernatant (especially the NADH). This extra step caused some mitochondrial damage (high control).
Treatment with 0.1 mM NADH and 19 nmol of DHC16 (but not DHC2) resulted in the permeabilization of the outer membrane. For A and
B, the results are means of three experiments 6 SD. ** P , 0.01. C: The release of adenylate kinase increases when the mitochondria
are incubated with NADH and DHC16. Mitochondria were incubated for the indicated times with NADH alone (open circles), NADH
plus DHC16 (closed triangles), or no treatment (closed circles), followed by quantitating the amount of adenylate kinase released into
the medium. Treating the mitochondria with DHC16 alone did not release significant amounts of adenylate kinase (not shown). The
results are expressed as a percentage of the total activity released after hypotonic shock of the mitochondria. Error bars indicate SD of
three experiments.
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occurs after the addition of ceramide saturates after
10 min (4). Here, with dihydroceramide there is a 30 min
lag followed by a transient increase in permeability. This
lag could be attributed to a number of factors: meta-
bolic rate, rate of transfer of ceramide from MAM to mito-
chondria, and the ability of dihydroceramide to interfere
with ceramide channel formation (5). The latter effect
was predicted to cause a sudden increase in outer mem-
brane permeability as dihydroceramide levels decline
while ceramide levels increase (5). Figure 1 shows a sudden
rapid increase.
The permeabilization seems to be the result of DDase
activity. It could not be achieved with NADH alone, if
NADH was substituted by NAD1, or if short-chain DHC2-
ceramide was used instead of DHC16-ceramide (Fig. 1B).
The DDase requires NADH and does not desaturate short-
chain dihydroceramide (25).
When adenylate kinase release was used to monitor
outer membrane permeabilization (Fig. 1C), the kinetics
were much faster. This is not surprising, because ade-
nylate kinase is released even by the formation of transient
pathways. It accumulates in the medium, and no further
release occurs once the concentrations in the intermem-
brane space and the medium are equal. Thus, the amount
of enzyme in the medium is the integral of the rate of
efflux times the time. By contrast, the cytochrome c oxida-
tion assay measures the permeability of the outer mem-
brane to cytochrome c at one point in time as the rate
of cytochrome c oxidation. Thus, this assay monitors the
actual permeability at that particular moment in time
and cannot detect the effect of permeability increases
at other times. Note that the permeability peaks were fol-
lowed by a reduction, possibly caused by the movement
of ceramide into other nonconducting structures or cer-
amide hydrolysis.
The most straightforward interpretation of these results
is that isolated rat liver mitochondria contain a DDase
activity. Is this located in the mitochondria proper or the
associated MAM?
A DDase capable of using cytosolic NADH is not found in
ultrapure mitochondria isolated from rat liver
We looked for DDase activity in mitochondria isolated
by differential centrifugation (DC-mitochondria) by add-
ing radiolabeled dihydroceramide (1-14C-DHC8) and look-
ing for conversion to ceramide. Samples were resolved on
a TLC plate, and the amount of radioactivity in ceramide
and dihydroceramide is visualized in Fig. 2A. Unlabeled
sphingolipids were added to the samples at the end of the
incubation period to act as carriers and to confirm separa-
tion on the TLC plate (Fig. 2B). Significant conversion of
dihydroceramide to ceramide was observed (Fig. 2, M).
However, because mitochondria isolated by differential
centrifugation have associated membranes (MAM), we re-
moved these using a Percoll gradient as described pre-
viously (18, 20) to generate ultrapure mitochondria.
Percoll somehow dissociates these membranes from
the mitochondria. These ultrapure mitochondria had no
significant DDase activity (Fig. 2, UP). The ER fraction
(Fig. 2, ER) showed the largest conversion (44 6 5% in
45 min, average and SD of 23 experiments). The results
for these ultrapure mitochondria indicate that the enzyme
is not found in mitochondria from rat liver in a detectable
amount (Fig. 2, UP), but the tight interaction between
mitochondria and ER is what causes this conversion in
the DC-mitochondrial fraction. After an ER marker en-
zyme assay (NADPH:cytochrome c reductase), the DC-
mitochondria had double the activity (13.5 mM/mg/min)
of the ultrapure (5.8 mM/mg/min) but significantly less
than the ER (426 mM/mg/min). Although, by this en-
zyme, one might conclude that some MAM membranes
are still associated with the ultrapure mitochondria de-
spite the loss of DDase activity, no marker is perfect and
there is a small amount of NADPH:cytochrome c reductase
in mitochondria (31).
The ability of added dihydroceramide and NADH to
permeabilize the mitochondrial outer membrane to pro-
teins, as illustrated in Fig. 1, seems to arise from ceramide
generation in the MAM and its subsequent transfer to the
mitochondrial outer membrane.
Ultrapure mitochondria isolated from rat liver have
minimal DDase activity in both membranes
Membrane compartmentation may have prevented the
detection of DDase activity in mitochondria. To check
whether the DDase is found in the inner membrane of
mitochondria using matrix NADH, NADH was produced
in the matrix using the malate/glutamate shuttle (32).
Fig. 2. Dihydroceramide desaturase (DDase) capable of using
cytosolic NADH was not found in mitochondria stripped of
mitochondria-associated membranes (MAMs). A: PhosphorImager
screen of a TLC plate showing the conversion of added radioac-
tive N-[1-14C]octanoyl-D-erythro-sphinganine (1-14C-DHC8) to radio-
active N-[1-14C]-octanoyl-D-erythro-sphingosine (C8) with different
additions: no organelles (C), ultrapure mitochondria (UP), mito-
chondria obtained by differential centrifugation (M), and endo-
plasmic reticulum (ER). B: Iodine staining of the same plate.
Unlabeled DHC8 and C8 were added to each sample before ex-
traction so that it would act as a carrier for the label and to clearly
indicate the location of the two compounds on the TLC plate. The
lipids were extracted from the same amounts of organellar protein
(0.6 mg of protein per lane, except for C). All of the extracted
lipids were applied to the TLC plate. Ultrapure mitochondria were
purified on a Percoll gradient.
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The mitochondria used here were Percoll-purified, with a
broken outer membrane to allow maximal accessibility to
the inner membrane. Thus, 4 mM NADH was present
in the medium, whereas NADH was maintained high in
the matrix by the malate/glutamate shuttle. The TLC re-
sults (Fig. 3A) show virtually no difference between 0 min
of incubation (BMcont) and 45 min of incubation (BM).
Subtraction of the curves (Fig. 3B) shows a slight radio-
active ceramide peak consistent with ?8.4 6 1.3% conver-
sion. This is 3.7% of the specific activity in the ER. For
comparison, the NADPH:cytochrome c reductase marker
enzyme activity was 3.2% and 1.4% of the specific activity
of the ER in DC- and Percoll-treated mitochondria,
respectively. Recovered ER from the Percoll-treated mito-
chondria showed the same conversion of dihydroceramide
to ceramide, ruling out the notion that Percoll inhibits
this enzyme.
Medium-chain DHC8 and C8 and long-chain C16 in
the ER can be transferred to mitochondria in a
time-dependent manner
The straightforward interpretation from the experi-
ments illustrated in Figs. 1 and 2 is that dihydroceramide is
converted to ceramide in the MAM and then transferred
to the mitochondrial outer membrane, resulting in cer-
amide channel formation and permeabilization to cyto-
chrome c and adenylate kinase. A direct demonstration of
the ability of ceramide to translocate from ER membranes
to mitochondria was undertaken to test this hypothesis.
Radiolabeled ceramide was generated in ER vesicles
by incubating these with NADH and 1-14C-DHC8. After
45 min, these were incubated with mitochondria for
10 min, followed by separation of the organelles by dif-
ferential centrifugation. The ER marker enzyme assay was
used to determine the effectiveness of separating ER from
mitochondria, and the separation was effective (only 1.4%
of the ER marker enzyme activity was recovered in mito-
chondria). Lipid extractions were performed followed by
separation of ceramide from dihydroceramide on TLC
(Fig. 4A). Ceramide and dihydroceramide bands were
present in both mitochondria and ER. The transfer of
these lipids occurred with a half-life of 5–10 min (Fig. 4B).
A similar rate of transfer was seen in the reverse direction
(data not shown). This rate has not been reported in the
literature, so we decided to estimate it from the published
rates of transfer of C16-ceramide. The rate of transfer of
ceramide from the donor membrane can be calculated
from the results of Simon, Holloway, and Gear (33) using
Eyring rate theory and an energy deficit of 3 kJ/methylene
group. Thus, for C8-ceramide, the rate constant for this
process is calculated to be 1.6 min21. Therefore, an ex-
change of 15% should occur within 70 s. This is consistent
with our observations, considering that there may be other
steps in the exchange process that could slow the mea-
sured rate. Nevertheless, the exchange observed with the
C8-ceramide can be accounted for by a simple physical
exchange process.
The energy barrier for long-chain ceramide would be
much greater than that for C8-ceramide, and a simple phys-
ical exchange could not account for the results illustrated
in Fig. 1. We examined the possibility that a mechanism
might be present to accelerate the transfer of long-chain
ceramide from ER to mitochondria. Exchange experi-
ments were performed with endogenously produced
[3H]palmitoyl-D-erythro-sphingosine-ceramide. [3H]sphin-
gosine and palmitoyl-CoA were added to ER preparations
to endogenously synthesize [3H]palmitoyl-D-erythro-sphin-
gosine-ceramide in the ER membrane using the enzyme
ceramide synthase. Excess sphingosine was removed with
BSA. Figure 4C shows that the transfer of the ceramide
from ER to mitochondria occurs in a time-dependent
manner at a rate much faster than that of spontaneous
transfer (35 h for 20% transfer) (33). Controls lacking
palmitoyl-CoA resulted in essentially no production of
radiolabeled ceramide and essentially no ceramide in the
mitochondrial fraction, despite comparable amounts of
sphingosine transport (Fig. 4D). Thus, the translocation
of sphingosine to mitochondria, under these conditions,
did not result in a significant conversion to ceramide in
the mitochondrial membranes. Therefore, ceramide was
transferred rapidly from ER vesicles to mitochondria, and
thus, the ER must contain some system to catalyze this
translocation process.
The transfer of long-chain ceramide into mitochondria
depends on the concentrations of organelles used
To further test the theory that random collisions be-
tween ER vesicles and mitochondria might account for
the transfer of ceramide, a dilution experiment was per-
formed to determine whether the transfer rate depended
Fig. 3. The DDase associated with mitochondria is minimal. A:
PhosphorImager screen of a TLC plate showing minimal conver-
sion of 1-14C-DHC8 to C8 in Percoll-purified mitochondria with
broken outer membrane supplied with NADH externally and main-
tained in the matrix by providing malate/glutamate. Sample BM
was incubated for 45 min, and sample BMcont was incubated for
zero time. B: The traces were quantified as a function of migration
distance in pixels and plotted. The inset shows the subtraction of
the zero-time control from the experimental sample, BM. A peak
possibly attributable to ceramide was detected. In three indepen-
dent experiments, the area was found to represent 8.4 6 1.3%
(6SD) conversion in 45 min per 3 mg of protein. In contrast, the
ER fraction achieved 44 6 5% conversion in 45 min with 0.6 mg of
protein. a.u., arbitrary units.
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on the concentration of organelles. A bimolecular process
depends on the square of the concentrations of the re-
actants. Thus, by reducing the concentrations of each of
the interacting organelles by half, the transfer rate should
decline by a factor of 4. Other processes would predict
different outcomes. For example, if the organelles ad-
hered to each other, then the dilution would have a much
weaker effect. ER vesicles were incubated with [3H]sphin-
gosine and palmitoyl-CoA (similar to the experiments out-
lined above). Mitochondria were added, and after 10 min
of incubation, the organelles were separated and the lipids
were extracted and run on a TLC plate. The results ob-
tained for long-chain ceramide were 3346 36 dpm for the
undiluted sample and 99 6 14 dpm for the diluted sam-
ple. This result is not significantly different from a 4-fold
dilution effect. It is significantly different from both a
2-fold effect (P, 0.02) and no dilution effect (P, 0.005).
These results represent the average and SEM of three
experiments. Hence, this indicates that the transfer occurs
by random collision of the organelles.
}
Fig. 4. Both medium- and long-chain ceramide transfer from ER to mitochondria in a time-dependent manner. A: PhosphorImager screen
of a TLC plate showing the transfer of medium-chain ceramide from ER to mitochondria. After the production of ceramide in the
ER, Percoll-treated mitochondria were incubated with the ER for the indicated times and then the organelles were separated by cen-
trifugation. The lipids were extracted from the low-speed spin pellet (M) and the high-speed spin pellet (ER). Equal amounts of protein
were used in these experiments. B: The percentage total radioactivity recovered in the mitochondria (closed circles) and ER (open circles)
is shown as an average of four separate, independent experiments 6 SEM. C: ER vesicles were preloaded with radiolabeled long-chain
ceramide using [3H]sphingosine and palmitoyl-CoA. Preloaded ER vesicles were incubated with mitochondria at room temperature for
0, 5, and 10 min, resulting in a slow but steady transfer of ceramide from the ER (closed circles) to mitochondria (open circles). Mito-
chondria were checked for the percentage of ER marker enzyme contamination (closed triangles). The results represents averages 6 SEM
of three replicates. D: The addition of palmitoyl-CoA is vital for the development of a ceramide band in the mitochondrial extract.
ER vesicles were incubated with [3H]sphingosine with and without palmitoyl-CoA, washed, and then incubated with mitochondria for
10 min. A transfer of both sphingosine (sph) and ceramide (C16) is observed. However, only when palmitoyl-CoA is present in the ER to
produce ceramide by ceramide synthase is a ceramide band detected in mitochondria (mito). Results represent averages 6 SD of three
independent experiments.
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Mitochondrial outer membrane permeabilization by
interaction with long-chain ceramide-containing
ER vesicles
The transfer of ceramide from ER membranes to
mitochondria is no more than a curiosity unless it results
in functional changes. Aliquots of mitochondria were
mixed with ER vesicles pretreated with NADH and DHC16
to preload them with ceramide, or with untreated ER ves-
icles, or with medium alone. The mitochondria-ER combi-
nations were incubated for the indicated times (Fig. 5),
and then the cytochrome c oxidation rate was measured.
The permeabilization of the outer membrane to cyto-
chrome c is once again expressed as a percentage of the
rate observed with shocked mitochondria. Only mitochon-
dria exposed to ER vesicles preloaded with ceramide
developed an outer membrane permeabilized to proteins.
Note that the development of permeability occurred at
a much faster rate than that in Fig. 1A, where ceramide
could only be generated by the relatively small amount of
membranes associated with the mitochondria.
DISCUSSION
There is general consensus that the increase of cer-
amide levels in cells is associated with or leads to the onset
of apoptosis (34). Ceramide is increased in different mem-
brane compartments and has a variety of effects. We are
interested in its ability to increase the permeability of the
mitochondrial outer membrane to proteins (4) and the
consequential release of proapoptotic proteins into the
cytosol. The increase of ceramide levels in mitochondria,
which has been reported early in apoptosis (35–37), begs
the question: where does it come from?
The conversion of dihydroceramide, existing in the
outer membrane, to ceramide is one possibility. In mito-
chondria isolated from rat liver, we detected substantial
DDase activity when the mitochondria were associated
with MAM but only trace levels of this activity in mito-
chondria purified with Percoll to dissociate the MAM.
These results are consistent with previous reports (38).
However, other sources of mitochondria seem to have
substantial amounts of DDase activity that may not be
accounted for by MAM (39). The mitochondrial proteome
varies from tissue to tissue, and it is also possible that
DDase is activated or introduced into mitochondria under
specific physiological conditions, such as early in apopto-
sis. Thus, the conversion of existing dihydroceramide to
ceramide is one possible pathway.
Another pathway is the generation of ceramide from
sphingosine either by ceramide synthase or by the reverse
action of ceramidase, both reported to be present in
mitochondria. However, cellular sphingosine levels are
quite low (40), and one might wonder if this source could
be sufficient. Unlike ceramide, sphingosine is quite pro-
miscuous. Having a single hydrocarbon acid chain, it
moves from one membrane to another quite readily. Thus,
if sphingosine were generated in one part of the cell, the
mitochondrial enzymes mentioned above could consume
it and thus increase mitochondrial ceramide levels.
We present a whole different pathway: direct exchange
of ceramide from ER or MAM to mitochondria. We
showed that this can occur and, for the physiologically
present long-chain ceramide, does so at a much faster rate
than expected from published experiments with lipo-
somes (reviewed in Ref. 41). Thus, the transfer appears
to be catalyzed. Regardless, we have raised the possibility
that mere proximity between mitochondria and ER
membranes containing ceramide can result in the delivery
of ceramide to mitochondria. The amount delivered is
sufficient to permeabilize the outer membrane to proteins
and therefore has functional significance. The transfer is
sufficient to increase the steady-state levels of ceramide in
mitochondria to the point that channels are formed. Thus,
this transfer must, in some way, overwhelm the ability of
mitochondrial ceramidase to hydrolyze ceramide.
Because ceramide is routinely generated in the ER for
sphingomyelin synthesis and transfer to the plasma mem-
brane, what keeps this ceramide from moving to mito-
chondria and initiating inappropriate apoptosis? We
propose that what is required is intimate contact with
mitochondrial membranes. It is well established that the
proteins and lipids are sorted in the ER; thus, ceramide
must be sorted in such a way that, under normal con-
ditions, it does not travel to mitochondria or else does so
at a very slow rate. Indeed, the ER-like membranes, the
MAM, that are in intimate contact with mitochondria
have different lipid and protein compositions from those
of the ER in general. Thus, guided delivery of ceramide to
Fig. 5. The addition of ceramide-containing ER to mitochondria
isolated by differential centrifugation induced permeabilization to
cytochrome c. Mitochondria were incubated for 10 min with un-
treated ER vesicles (open circles), ER vesicles pretreated with
NADH and DHC16 for the indicated times (closed triangles), or no
treatment (closed circles), followed by measurement of their ability
to oxidize cytochrome c as a function of time after the treatment.
The no-treatment measurement was only done after the 10 min
mock incubation. Its line is extended to later times to better
visualize differences between the different ER treatments. Perme-
abilization is the cytochrome c oxidation rate expressed as a per-
centage of the rate after hypotonic shock. The results are expressed
as means 6 SD of three experiments.
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mitochondria might occur only during the initial phases
of apoptosis.
The ability of lipids to travel from the ER to mitochondria
is not a novel finding. For instance, most of the enzymes of
the phospholipid synthetic pathway reside in the ER (42).
However, some enzymes, such as phosphatidylserine decar-
boxylase, are located in mitochondria (43). This enzyme
is critical for the formation of phosphatidylethanolamine
from phosphatidylserine (43–45). Thus, the synthesis of
phosphatidylethanolamine requires that phosphatidylser-
ine, made in the ER, move into mitochondria, where it is
decarboxylated, forming phosphatidylethanolamine, which
then returns to the ER (21, 45–48). Experimental evidence
indicates that membrane contact between the ER and mito-
chondria is responsible for rapid lipid exchange (reviewed
comprehensively in Refs. 49, 50) rather than vesicular
transport (44, 51).
A close interaction between ER and mitochondria has
been inferred from functional studies (19, 21). This
conclusion is strongly supported by ultrastructural obser-
vations (18, 20, 22). These show intimate contact between
ER-like vesicles and mitochondria. Thus, our proposal of
the direct exchange of ceramide between these compart-
ments is well supported by the literature.
Sphingolipids are known to be transferred from the ER
to the Golgi and plasma membrane by vesicular transport
(reviewed in Refs. 52, 53), but it is not known how and
whether sphingolipids travel between the ER and mito-
chondria by this process. To date, there has been no evi-
dence of the involvement of mitochondria in any vesicular
transport. The soluble protein, CERT (23, 54), has been
shown to transport ceramide from the ER to the Golgi.
Although similar methods might be used to transport
ceramide to mitochondria, these methods are unlikely
to play a role in the in vitro studies presented here. The
purification of mitochondria and ER vesicles would have
washed away soluble factors. The BSA used in the early
isolation steps was washed out in the later steps. Thus, the
results are consistent with a catalyzed exchange through
simple membrane contact. In vivo, the cellular organiza-
tion limits contact between organelles. Thus, the structure
of the cell may determine which membranes come in
contact and where exchange occurs.
Based on our results, we propose that the mitochon-
drion and its associated MAM form a functional unit for
ceramide generation and the subsequent release of pro-
teins from mitochondria. A similar idea of a functional
unit was proposed for calcium ion fluxes and their role in
mitochondrial function (for recent review, see Ref. 55).
This functional unit could allow for greater regulation by
providing more points of control. It also obviates the need
for a duplicate set of metabolic enzymes in both mem-
brane systems. If so, then why is there a ceramide synthase
in mitochondria? Perhaps the mitochondrial ceramide
synthase is a salvage pathway. It converts sphingosine pro-
duced from ceramide hydrolysis back into ceramide. The
activities of mitochondrial ceramide synthase and cer-
amidase may act to bias the system toward or away from
apoptosis by controlling the steady-state ceramide level.
As already stated, increases in mitochondrial ceramide
levels often occur early in apoptosis (35–37), and these are
consistent with the formation of ceramide channels (6).
However, such increases are not mandatory, as changes
in the level of antiapoptotic proteins also change the pro-
pensity for ceramide channel formation (56). Thus, in
cases in which cells undergo apoptosis without measurable
changes in mitochondrial ceramide levels, other factors
may result in ceramide channel formation.
In conclusion, we have shown that ceramide generated
in ER membranes from dihydroceramide or sphingosine
can be rapidly transferred to mitochondria and result in
the permeabilization of the outer membrane to proteins.
This result contributes to a growing body of evidence that
ceramide channels formed in the mitochondrial outer
membrane initiate the execution phase of apoptosis by
releasing proapoptotic proteins from mitochondria. This
and other sources of mitochondrial ceramide can increase
the steady-state level of ceramide to the point at which it
self-assembles into channels. We propose that mitochon-
dria surrounded by MAM form a functional unit serving a
number of functions, including the ceramide-induced
release of proteins from mitochondria.
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